A Real-World Study on the Clinical Characteristics, Outcomes, and Relationship between Antibiotic Exposure and Clostridioides difficile Infection
-
Published:2024-02-01
Issue:2
Volume:13
Page:144
-
ISSN:2079-6382
-
Container-title:Antibiotics
-
language:en
-
Short-container-title:Antibiotics
Author:
Vintila Bogdan Ioan12, Arseniu Anca Maria3, Morgovan Claudiu3ORCID, Butuca Anca3ORCID, Bîrluțiu Victoria24ORCID, Dobrea Carmen Maximiliana3ORCID, Rus Luca Liviu3ORCID, Ghibu Steliana5ORCID, Bereanu Alina Simona12, Arseniu Rares6, Roxana Codru Ioana12ORCID, Sava Mihai12, Gabriela Gligor Felicia3ORCID
Affiliation:
1. Clinical Surgical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 550169 Sibiu, Romania 2. County Clinical Emergency Hospital, 550245 Sibiu, Romania 3. Preclinical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 550169 Sibiu, Romania 4. Clinical Medical Department, Faculty of Medicine, “Lucian Blaga” University of Sibiu, 550169 Sibiu, Romania 5. Department of Pharmacology, Physiology and Pathophysiology, Faculty of Pharmacy, “Iuliu Hatieganu” University of Medicine and Pharmacy, 400012 Cluj-Napoca, Romania 6. County Emergency Clinical Hospital ”Pius Brînzeu”, 300723 Timișoara, Romania
Abstract
Clostridioides difficile is a Gram-positive bacteria that causes nosocomial infections, significantly impacting public health. In the present study, we aimed to describe the clinical characteristics, outcomes, and relationship between antibiotic exposure and Clostridioides difficile infection (CDI) in patients based on reports from two databases. Thus, we conducted a retrospective study of patients diagnosed with CDI from Sibiu County Clinical Emergency Hospital (SCCEH), Romania, followed by a descriptive analysis based on spontaneous reports submitted to the EudraVigilance (EV) database. From 1 January to 31 December 2022, we included 111 hospitalized patients with CDI from SCCEH. Moreover, 249 individual case safety reports (ICSRs) from EVs were analyzed. According to the data collected from SCCEH, CDI was most frequently reported in patients aged 65–85 years (66.7%) and in females (55%). In total, 71.2% of all patients showed positive medical progress. Most cases were reported in the internal medicine (n = 30, 27%), general surgery (n = 26, 23.4%), and infectious disease (n = 22, 19.8%) departments. Patients were most frequently exposed to ceftriaxone (CFT) and meropenem (MER). Also, in the EV database, most CDI-related ADRs were reported for CFT, PIP/TAZ (piperacillin/tazobactam), MER, and CPX (ciprofloxacin). Understanding the association between previous antibiotic exposure and the risk of CDI may help update antibiotic stewardship protocols and reduce the incidence of CDI by lowering exposure to high-risk antibiotics.
Funder
Lucian Blaga University of Sibiu
Subject
Pharmacology (medical),Infectious Diseases,Microbiology (medical),General Pharmacology, Toxicology and Pharmaceutics,Biochemistry,Microbiology
Reference70 articles.
1. Popa, D., Neamtu, B., Mihalache, M., Boicean, A., Banciu, A., Banciu, D.D., Moga, D.F.C., and Birlutiu, V. (2021). Fecal Microbiota Transplant in Severe and Non-Severe Clostridioides Difficile Infection. Is There a Role of FMT in Primary Severe CDI?. J. Clin. Med., 10. 2. Chiș, A.A., Rus, L.L., Morgovan, C., Arseniu, A.M., Frum, A., Vonica-țincu, A.L., Gligor, F.G., Mureșan, M.L., and Dobrea, C.M. (2022). Microbial Resistance to Antibiotics and Effective Antibiotherapy. Biomedicines, 10. 3. Czepiel, J., Dróżdż, M., Pituch, H., Kuijper, E.J., Perucki, W., Mielimonka, A., Goldman, S., Wultańska, D., Garlicki, A., and Biesiada, G. (2019). Clostridium Difficile Infection: Review. Eur. J. Clin. Microbiol. Infect. Dis., 38. 4. Our Experience with 80 Cases of SARS-CoV-2-Clostridioides Difficile Co-Infection: An Observational Study;Birlutiu;Medicine,2022 5. Centers for Disease Control and Prevention (2013). Antibiotic Resistance Threats in the United States, Centers for Disease Control and Prevention.
|
|